000			01614 a2200445 4500
005			20250516030842.0
264		0	_c20111207
008			201112s 0 0 eng d
022			_a1522-9645
024	7		_a10.1093/eurheartj/ehr052 _2doi
040			_aNLM _beng _cNLM
100	1		_aSteffel, Jan
245	0	0	_aNovel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism. _h[electronic resource]
260			_bEuropean heart journal _cAug 2011
300			_a1968-76, 1976a p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAcute Coronary Syndrome _xeconomics
650	0	4	_aAdministration, Oral
650	0	4	_aAnticoagulants _xadministration & dosage
650	0	4	_aAtrial Fibrillation _xdrug therapy
650	0	4	_aBenzimidazoles _xtherapeutic use
650	0	4	_aCost-Benefit Analysis
650	0	4	_aDabigatran
650	0	4	_aDrug Approval
650	0	4	_aFactor X _xantagonists & inhibitors
650	0	4	_aHumans
650	0	4	_aMorpholines _xtherapeutic use
650	0	4	_aOff-Label Use
650	0	4	_aPyrazoles _xtherapeutic use
650	0	4	_aPyridines _xtherapeutic use
650	0	4	_aPyridones _xtherapeutic use
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRivaroxaban
650	0	4	_aStroke _xeconomics
650	0	4	_aThiophenes _xtherapeutic use
650	0	4	_aVenous Thromboembolism _xdrug therapy
700	1		_aBraunwald, Eugene
773	0		_tEuropean heart journal _gvol. 32 _gno. 16 _gp. 1968-76, 1976a
856	4	0	_uhttps://doi.org/10.1093/eurheartj/ehr052 _zAvailable from publisher's website
999			_c20692015 _d20692015